TP53 and acute myeloid leukemia: Our analysis showed impact of age at diagnosis, race, mutations (especially TP53), and treatment patterns (including BMT, chemotherapy, hospitalization, and percentage of appointments attended) on sex differences in overall survival following AML diagnosis.